Schedule 13G ownership disclosure

Soleno Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 834203309

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Adage Capital Management, L.P.

    Shares: 2,775,976.00 · Class: 6.44%

  • Adage Capital Partners GP, L.L.C.

    Shares: 0.00 · Class: 0%

  • Robert Atchinson

    Shares: 2,775,976.00 · Class: 6.44%

  • Phillip Gross

    Shares: 2,775,976.00 · Class: 6.44%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-000867
Form type
SCHEDULE 13G/A
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub